News Ozempic Comes To India At Rs 2,200 Weekly Dose, Novo Nordisk Cautions Against Unsupervised Use Ozempic has been approved for type-2 diabetes, while Novo Nordisk’s other global blockbuster Wegovy is targeted at obesity. Post navigation Previous: 8 In 10 Airline Passengers Experienced ‘Dark Patterns’ In 1 year, Mostly On Indigo: SurveyNext: ‘Ready To Discuss, Find Solution’: Centre To Opposition’s Air Pollution Debate Demand In Lok Sabha More Stories News 500 Maharashtrian Tourists Return From Dubai As MahaHelpline Steps In Amid Flight Disruptions News Book Review | The Policy Pivot: Inside India’s Strategic Shift News News18 Evening Digest: Trump Promises ‘Complete Destruction, Certain Death’ In Tehran, Iran Apologises To Neighbours